TCIM
ARNA

TIAA CREF Investment Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

TIAA CREF Investment Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$8.04M Sell
179,307
-2,571
-1% -$118K 0.01% 1156
2018
Q4 		$7.08M Sell
181,878
-3,395
-2% -$133K 0.01% 1151
2018
Q3 		$8.53M Sell
185,273
-41,927
-18% -$1.7M 0.01% 1201
2018
Q2 		$9.91M Sell
227,200
-3,767
-2% -$162K 0.01% 1162
2018
Q1 		$9.12M Buy
230,967
+32,382
+16% +$1.26M 0.01% 1172
2017
Q4 		$6.75M Sell
198,585
-43,249
-18% -$1.23M ﹤0.01% 1418
2017
Q3 		$6.17M Buy
241,834
+132,378
+121% +$3.04M ﹤0.01% 1487
2017
Q2 		$1.85M Buy
109,456
+31,307
+40% +$429K ﹤0.01% 2227
2017
Q1 		$1.14M Buy
78,149
+8,830
+13% +$131K ﹤0.01% 2446
2016
Q4 		$984K Sell
69,319
-7,350
-10% -$114K ﹤0.01% 2547
2016
Q3 		$1.34K Sell
76,669
-1,845
-2% -$30.6K ﹤0.01% 2384
2016
Q2 		$1.34M Sell
78,514
-6,229
-7% -$111K ﹤0.01% 2370
2016
Q1 		$1.67M Sell
84,743
-2,425
-3% -$38.9K ﹤0.01% 2184
2015
Q4 		$1.66M Sell
87,168
-2,618
-3% -$53.4K ﹤0.01% 2282
2015
Q3 		$1.72M Sell
89,786
-23,328
-21% -$792K ﹤0.01% 2244
2015
Q2 		$5.25M Sell
113,114
-18,921
-14% -$821K ﹤0.01% 1648
2015
Q1 		$5.77M Buy
132,035
+15,302
+13% +$711K ﹤0.01% 1537
2014
Q4 		$4.05M Sell
116,733
-5,548
-5% -$225K ﹤0.01% 1774
2014
Q3 		$5.12M Buy
122,281
+11,033
+10% +$493K ﹤0.01% 1601
2014
Q2 		$6.52M Buy
111,248
+10,883
+11% +$685K ﹤0.01% 1479
2014
Q1 		$6.32M Sell
100,365
-506
-0.5% -$33.6K ﹤0.01% 1448
2013
Q4 		$5.9M Sell
100,871
-2,505
-2% -$131K ﹤0.01% 1513
2013
Q3 		$5.45M Sell
103,376
-918
-0.9% -$61.6K ﹤0.01% 1519
2013
Q2 		$8.03M Buy
+104,294
New +$8.51M 0.01% 1188

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

TIAA CREF Investment Management's ARNA Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Arena Pharmaceuticals Inc (ARNA) stake by 1.4% in Q1 2019, selling an estimated $118K and leaving 179,307 shares worth $8.04M. The position accounts for 0.01% of the portfolio, ranked #1156.

TIAA CREF Investment Management first reported a position in ARNA in Q2 2013 and has held it in 24 quarters since. The position peaked at $9.91M in Q2 2018. 184 funds tracked by Wall St. Rank hold ARNA as of Q1 2019.

  • TIAA CREF Investment Management held 179,307 shares of Arena Pharmaceuticals Inc worth $8.04M as of Q1 2019.
  • TIAA CREF Investment Management sold 2,571 Arena Pharmaceuticals Inc shares in Q1 2019, an estimated $118K.
  • Arena Pharmaceuticals Inc made up 0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1156 holding.
  • TIAA CREF Investment Management first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Arena Pharmaceuticals Inc position peaked at $9.91M in Q2 2018.
  • 184 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.